Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Related Articles by Review for PubMed (Select 9259029)

3.

Glycopeptides in the treatment of staphylococcal infections.

Daschner FD, Kropec A.

Eur J Clin Microbiol Infect Dis. 1995;14 Suppl 1:S12-7. Review.

PMID:
7729466
4.

Burden of methicillin-resistant Staphylococcus aureus: focus on clinical and economic outcomes.

Lodise TP Jr, McKinnon PS.

Pharmacotherapy. 2007 Jul;27(7):1001-12. Review.

PMID:
17594206
5.

Methicillin-resistant Staphylococcus aureus: the superbug.

Ippolito G, Leone S, Lauria FN, Nicastri E, Wenzel RP.

Int J Infect Dis. 2010 Oct;14 Suppl 4:S7-11. doi: 10.1016/j.ijid.2010.05.003. Epub 2010 Sep 20. Review.

6.

Who's winning the war?

Gould IM.

J Antimicrob Chemother. 2008 Nov;62 Suppl 3:iii3-6. doi: 10.1093/jac/dkn366. Review.

7.
8.

[New therapeutic strategies with teicoplanin].

Carbone E, Nacinovich F, Stamboulian D.

Medicina (B Aires). 2002;62 Suppl 2:25-9. Review. Spanish.

PMID:
12481485
9.

Antibiotic therapy of staphylococcal infections.

Hawks GH.

Can Med Assoc J. 1965 Oct 16;93(16):848-53. Review.

10.

[Significance of methicillin resistant S. aureus (MRSA) in geriatrics--epidemiology, therapy and management].

Albert S, Wichelhaus TA, Schäfer V.

Z Gerontol Geriatr. 2000 Oct;33(5):367-73. Review. German.

PMID:
11130190
11.

Key considerations in the treatment of complicated staphylococcal infections.

Jones RN.

Clin Microbiol Infect. 2008 Mar;14 Suppl 2:3-9. doi: 10.1111/j.1469-0691.2008.01923.x. Review.

PMID:
18226084
12.

Teicoplanin in the treatment of serious infection.

Schaison G, Graninger W, Bouza E.

J Chemother. 2000 Nov;12 Suppl 5:26-33. Review.

PMID:
11131961
13.

A systematic review and economic model of switching from non-glycopeptide to glycopeptide antibiotic prophylaxis for surgery.

Cranny G, Elliott R, Weatherly H, Chambers D, Hawkins N, Myers L, Sculpher M, Eastwood A.

Health Technol Assess. 2008 Jan;12(1):iii-iv, xi-xii, 1-147. Review.

14.

Nosocomial staphylococcal outbreaks.

Emmerson M.

Scand J Infect Dis Suppl. 1994;93:47-54. Review.

PMID:
8047857
15.

In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.

Schentag JJ, Birmingham MC, Paladino JA, Carr JR, Hyatt JM, Forrest A, Zimmer GS, Adelman MH, Cumbo TJ.

Semin Respir Infect. 1997 Dec;12(4):278-93. Review.

PMID:
9436955
16.

Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection.

Khare M, Keady D.

Expert Opin Pharmacother. 2003 Feb;4(2):165-77. Review.

PMID:
12562306
17.

The role of glycopeptide antibiotics in the treatment of infective endocarditis.

Grüneberg RN, Antunes F, Chambers HF, Garau J, Graninger W, Menichetti F, Peetermans WE, Pittet D, Shah PM, Vogelaers D.

Int J Antimicrob Agents. 1999 Aug;12(3):191-8. Review.

PMID:
10461836
18.

Antibiotics currently used in the treatment of infections caused by Staphylococcus aureus.

Rayner C, Munckhof WJ.

Intern Med J. 2005 Dec;35 Suppl 2:S3-16. Review. Erratum in: Intern Med J. 2006 Feb;36(2):142-3.

PMID:
16271060
19.

Containing methicillin-resistant S aureus. Surveillance, control, and treatment methods.

Simor AE.

Postgrad Med. 2001 Oct;110(4):43-8; quiz 11. Review.

PMID:
11675980
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk